Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema-Reference-Cited by-同舟云学术

Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema

Published:2018-01-09 Issue:3 Volume:7 Page:158-165
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Zhang Ying¹,Tortorici Michael A.¹^ORCID,Pawaskar Dipti¹,Pragst Ingo²,Machnig Thomas³,Hutmacher Matthew⁴,Zuraw Bruce⁵,Cicardi Marco⁶,Craig Timothy⁷,Longhurst Hilary⁸,Sidhu Jagdev⁹

Affiliation:

1. Clinical Pharmacology and Early Development; CSL Behring; King of Prussia Pennsylvania USA

2. Global Clinical Research, CSL Behring GmbH; Marburg Germany

3. Department of Global Clinical Development/Medical Affairs; CSL Behring GmbH; Marburg Germany

4. Deceased. Ann Arbor Pharmacometrics Group; Ann Arbor Michigan USA

5. Department of Medicine; University of California, San Diego; La Jolla California USA

6. Ospedale Luigi Sacco-UO Medicina Generale; Milan Italy

7. Department of Medicine; Pediatrics and Graduate Studies, Penn State University; Hershey Pennsylvania USA

8. Barts Health NHS Trust; London UK

9. Clinical Pharmacology and Early Development; CSL Limited; Parkville Australia

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Reference11 articles.

1. Clinical practice. Hereditary angioedema;Zuraw;N. Engl. J. Med.,2008

2. Meeting the challenges and burdens associated with hereditary angioedema;Toscani;Manag. Care,2011

3. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency;Zuraw;J. Allergy Clin. Immunol. Pract.,2013

4. WAO guideline for the management of hereditary angioedema;Craig;World Allergy Organ. J.,2012

5. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate;Zuraw;Allergy,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology;Advances in Therapy;2023-01-07

2. The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency;International Journal of Molecular Sciences;2022-09-07

3. Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management;Clinical Therapeutics;2021-12

4. Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2;Clinical Reviews in Allergy & Immunology;2021-01-09

5. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema;The Journal of Allergy and Clinical Immunology: In Practice;2021-01